Access Resources
4051 - 4075 of 7540 Results
Title
Year
- Cross-Platform Comparison of Immunoassay Technologies to Assess Cytokine Markers in Patients With Post-Traumatic Stress Disorder and Parkinson’s Disease2020RESTRICTEDTitle: Cross-Platform Comparison of Immunoassay Technologies to Assess Cytokine Markers in Patients With Post-Traumatic Stress Disorder and Parkinson’s DiseaseJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 87Issue #: 9Start Page: S378End Page: S378Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2020.02.968Citation Count: 0
-
RESTRICTEDTitle: Deciphering DDX3X Syndrome to Capture Determinants of Intellectual DisabilityJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 87Issue #: 9Start Page: S378End Page: S379Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2020.02.969Citation Count: 0
- Do Parkinson disease subject and caregiver-reported Epworth sleepiness scale reponses correlate?2020RESTRICTEDTitle: Do Parkinson disease subject and caregiver-reported Epworth sleepiness scale reponses correlate?Journal Name: Clinical Neurology and NeurosurgeryPublisher: Elsevier BVVol: 192Issue #:Start Page: 105728End Page: 105728Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clineuro.2020.105728Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183413Citation Count: 2
-
RESTRICTEDTitle: ePresentation SessionsJournal Name: European Journal of NeurologyPublisher: WileyVol: 27Issue #: S1Start Page: 103End Page: 522Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.14307Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14307Citation Count: 4
- Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients2020RESTRICTEDTitle: Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic PatientsJournal Name: JAMA OncologyPublisher: American Medical Association (AMA)Vol: 6Issue #: 5Start Page: 714End Page: 714Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaoncol.2020.0001Best OA location URL: https://jamanetwork.com/journals/jamaoncology/articlepdf/2761984/jamaoncology_fehlmann_2020_oi_200001.pdfCitation Count: 83
-
RESTRICTEDTitle: Expert comment: “A case of missing pathology in a patient with LRRK2 Parkinson's disease”Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 74Issue #:Start Page: 78End Page: 79Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.005Citation Count: 3
- Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson’s Disease2020RESTRICTEDTitle: Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson’s DiseaseJournal Name: NeurosciencePublisher: Elsevier BVVol: 433Issue #:Start Page: 53End Page: 71Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2020.02.046Citation Count: 18
- Impact of Overweight and Obesity on Functional and Clinical Outcomes of Early Parkinson's Disease2020RESTRICTEDTitle: Impact of Overweight and Obesity on Functional and Clinical Outcomes of Early Parkinson's DiseaseJournal Name: Journal of the American Medical Directors AssociationPublisher: Elsevier BVVol: 21Issue #: 5Start Page: 697End Page: 700Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jamda.2019.11.019Citation Count: 11
-
RESTRICTEDTitle: Initiation of pharmacological therapy in Parkinson's disease: when, why, and howJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 5Start Page: 452End Page: 461Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30036-3Citation Count: 101
- Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synuclein2020RESTRICTEDTitle: Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synucleinJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 6Issue #: 18Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.aba1193Best OA location URL: https://advances.sciencemag.org/content/advances/6/18/eaba1193.full.pdfCitation Count: 39
-
RESTRICTEDTitle: Long-term unsupervised mobility assessment in movement disordersJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 5Start Page: 462End Page: 470Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30397-7Best OA location URL: https://pure.rug.nl/ws/files/121196279/Long_term_unsupervised_mobility_assessment_in.pdfCitation Count: 172
-
RESTRICTEDTitle: Magnetic Resonance Imaging and Neurofilament Light in the Differentiation of ParkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1388End Page: 1395Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28060Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316785Citation Count: 16
- Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The COVID‐19 Experience2020RESTRICTEDTitle: Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The COVID‐19 ExperienceJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 4Start Page: 361End Page: 372Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12965Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12965Citation Count: 92
-
RESTRICTEDTitle: Medical cannabis as an alternative therapeutics for Parkinsons’ disease: Systematic reviewJournal Name: Complementary Therapies in Clinical PracticePublisher: Elsevier BVVol: 39Issue #:Start Page: 101154End Page: 101154Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ctcp.2020.101154Citation Count: 17
-
RESTRICTEDTitle: Microglial exosomes facilitate α-synuclein transmission in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 5Start Page: 1476End Page: 1497Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa090Best OA location URL: https://academic.oup.com/brain/article-pdf/143/5/1476/33281811/awaa090.pdfCitation Count: 251
-
RESTRICTEDTitle: miRSwitch: detecting microRNA arm shift and switch eventsJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 48Issue #: W1Start Page: W268End Page: W274Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/nar/gkaa323Best OA location URL: https://academic.oup.com/nar/article-pdf/48/W1/W268/33432877/gkaa323.pdfCitation Count: 19
- Movement disorders rounds: A case of missing pathology in a patient with LRRK2 Parkinson's disease2020RESTRICTEDTitle: Movement disorders rounds: A case of missing pathology in a patient with LRRK2 Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 74Issue #:Start Page: 76End Page: 77Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374981Citation Count: 13
-
RESTRICTEDTitle: Neuroimaging the consciousness of self: Review, and conceptual-methodological frameworkJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 112Issue #:Start Page: 164End Page: 212Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neubiorev.2020.01.023Best OA location URL: https://doi.org/10.1016/j.neubiorev.2020.01.023Citation Count: 90
-
RESTRICTEDTitle: Oral SessionsJournal Name: European Journal of NeurologyPublisher: WileyVol: 27Issue #: S1Start Page: 1End Page: 102Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.14306Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14306Citation Count: 3
- Personalized prediction of depression in patients with newly diagnosed Parkinson's disease: A prospective cohort study2020RESTRICTEDTitle: Personalized prediction of depression in patients with newly diagnosed Parkinson's disease: A prospective cohort studyJournal Name: Journal of Affective DisordersPublisher: Elsevier BVVol: 268Issue #:Start Page: 118End Page: 126Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jad.2020.02.046Citation Count: 18
-
RESTRICTEDTitle: PINK1 and Parkin: team players in stress-induced mitophagyJournal Name: Biological ChemistryPublisher: Walter de Gruyter GmbHVol: 401Issue #: 6-7Start Page: 891End Page: 899Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1515/hsz-2020-0135Citation Count: 31
- Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's disease2020RESTRICTEDTitle: Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 74Issue #:Start Page: 43End Page: 49Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.04.009Citation Count: 42
-
RESTRICTEDTitle: Surgical Treatment of Parkinson DiseaseJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 293End Page: 307Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.ncl.2020.01.001Best OA location URL: http://manuscript.elsevier.com/S0733861920300013/pdf/S0733861920300013.pdfCitation Count: 12
-
RESTRICTEDTitle: Ten Unsolved Questions About Neuroinflammation in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 16End Page: 24Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28075Best OA location URL: https://inserm.hal.science/inserm-02568209/file/ReviewMDSinflammationRev11%20dgs%20eh.pdfCitation Count: 131
-
RESTRICTEDTitle: Treatment of Nonmotor Symptoms Associated with Parkinson DiseaseJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 269End Page: 292Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ncl.2019.12.003Citation Count: 21